Caspase-2 Mediated Apoptotic and Necrotic Murine Macrophage Cell Death Induced by Rough Brucella abortus by Chen, Fang & He, Yongqun
Caspase-2 Mediated Apoptotic and Necrotic Murine
Macrophage Cell Death Induced by Rough Brucella
abortus
Fang Chen, Yongqun He*
Unit for Laboratory Animal Medicine and Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, United States of
America
Abstract
Brucella species are Gram-negative, facultative intracellular bacteria that cause zoonotic brucellosis. Survival and replication
inside macrophages is critical for establishment of chronic Brucella infection. Virulent smooth B. abortus strain 2308 inhibits
programmed macrophage cell death and replicates inside macrophages. Cattle B. abortus vaccine strain RB51 is an
attenuated rough, lipopolysaccharide O antigen-deficient mutant derived from smooth strain 2308. B. abortus rough mutant
RA1 contains a single wboA gene mutation in strain 2308. Our studies demonstrated that live RB51 and RA1, but not strain
2308 or heat-killed Brucella, induced both apoptotic and necrotic cell death in murine RAW264.7 macrophages and bone
marrow derived macrophages. The same phenomenon was also observed in primary mouse peritoneal macrophages from
mice immunized intraperitoneally with vaccine strain RB51 using the same dose as regularly performed in protection
studies. Programmed macrophage cell death induced by RB51 and RA1 was inhibited by a caspase-2 inhibitor (Z-VDVAD-
FMK). Caspase-2 enzyme activation and cleavage were observed at the early infection stage in macrophages infected with
RB51 and RA1 but not strain 2308. The inhibition of macrophage cell death promoted the survival of rough Brucella cells
inside macrophages. The critical role of caspase-2 in mediating rough B. abortus induced macrophage cell death was
confirmed using caspase-2 specific shRNA. The mitochondrial apoptosis pathway was activated in macrophages infected
with rough B. abortus as demonstrated by increase in mitochondrial membrane permeability and the release of cytochrome
c to cytoplasm in macrophages infected with rough Brucella. These results demonstrate that rough B. abortus strains RB51
and RA1 induce apoptotic and necrotic murine macrophage cell death that is mediated by caspase-2. The biological
relevance of Brucella O antigen and caspase-2-mediated macrophage cell death in Brucella pathogenesis and protective
Brucella immunity is discussed.
Citation: Chen F, He Y (2009) Caspase-2 Mediated Apoptotic and Necrotic Murine Macrophage Cell Death Induced by Rough Brucella abortus. PLoS ONE 4(8):
e6830. doi:10.1371/journal.pone.0006830
Editor: Robin Charles May, University of Birmingham, United Kingdom
Received April 30, 2009; Accepted July 29, 2009; Published August 28, 2009
Copyright:  2009 Chen, He. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: These studies and F.C. were in part supported by a NIAID (http://www3.niaid.nih.gov/) R-21 grant (1R21AI057875-01) and a BMRC grant from the
University of Michigan (http://www.umich.edu/) to Y.H., and in part by the NIH/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious
Diseases Research (RCE, http://www.glrce.org/) Program. The authors wish to acknowledge membership within and support from the Region V ‘Great Lakes’ RCE
(NIH award 1-U54-AI-057153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: yongqunh@umich.edu
Introduction
Brucella species are Gram-negative, facultative intracellular
bacteria that cause brucellosis in humans and animals [1]. Human
brucellosis remains the most common zoonotic disease worldwide
with more than 500,000 new cases annually [2]. B. abortus infects
primarily cattle and is one of the common Brucella species that
afflict humans [2]. The brucellae disseminate or spread via the
blood and lymphatics where they multiply inside phagocytes and
cause bacteremia. Unlike many pathogenic bacteria, Brucella lacks
most of the classical virulence factors such as invasive proteases,
exotoxins, capsules, fimbriae, virulence plasmids, and lysogenic
phages [3]. Instead, Brucella virulence relies on its ability to survive
and replicate in the vacuolar phagocytic compartments of
macrophages. Brucella lipopolysaccharide (LPS) is a Brucella
virulence factor [4]. The LPS has three domains: lipid A, the
core oligosaccharide, and the O antigen (O-polysaccharide, or O-
side chain). The brucellae exhibit two phenotypes, i.e., smooth and
rough. Smooth Brucella strains include a complete LPS, while
rough Brucella strains do not contain or produce very low level O-
antigen. Smooth virulent Brucella strains, e.g., B. abortus strain 2308
(S2308), inhibit programmed cell death of infected human and
mouse macrophages [5,6,7]. For example, smooth B. suis infection
inhibits spontaneously occurring apoptosis in human macrophages
[5,6,7]. The inhibition of cell death facilitates the survival and
replication of smooth Brucella strains inside macrophages. In
contrast, many rough derivatives of B. abortus, B. melitensis, and B.
suis, deficient in the LPS O antigen (O-side chain), can not survive
inside macrophages and are therefore attenuated [8,9]. A number
of B. abortus rough strains are cytotoxic to macrophages and induce
macrophage cell death [9,10,11,12,13]. The underlying details of
the molecular mechanism of macrophage death induced by rough
Brucella strains remain obscure.
Several types of programmed cell death have been defined. These
include apoptosis, autophagy, and pyroptosis [14,15,16,17]. These
categories are based on criteria such as morphological alterations,
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most thoroughly studied aspect of programmed cell death is
apoptosis. Apoptosis is mediated by a family of evolutionarily
conserved proteases known as caspases [18]. Activation of caspases
leads to cell shrinkage, nuclear condensation, and oligonucleosomal
DNA fragmentation. There are two types of apoptotic caspases:
initiator (apical)caspases and effector (executioner)caspases. Initiator
caspases (e.g., caspase-2, 8, 9, 10) activate effector caspases (e.g.,
caspase-3, 6, 7) that digest specific proteins and/or activate other
specific caspases (e.g., caspase-1, 4, 5, 11, 12, 13, 14). Two well-
studied pathways of apoptosis are the mitochondrial (intrinsic) cell
deathpathwayand the cellsurfacedeathreceptor(extrinsic) pathway
[19]. The mitochondrial cell death pathway is characterized by
increased mitochondrial membrane permeability and the release of
cytochrome c [20]. Necrosis refers to the sum of changes that have
occurred secondaryto celldeath(e.g., apoptosis)after dead cells have
reached equilibrium with their surroundings. According to recent
nomenclature recommendations, necrosis is the end product of a cell
death process instead of a form of cell death in itself [17,21,22].
Although macrophages are highly adept at destroying bacteria,
modulation of macrophage cell death by some species of bacteria is
emerging as an important pathogenesis mechanism. One such
mechanism, pyroptosis, is a caspase-1-dependent pro-inflammatory
cell death [17]. Caspase-1 is required for induction of macrophage
cell death infected by many microbial species including Salmonella
typhimurium [23,24,25], Shigella flexneri [26], Legionella pneumophila [27],
and Mycobacterium tuberculosis [28]. The participating of caspase-2 has
also been reported in Salmonella-infected macrophages [29]. Our
previous microarray study indicates smooth virulent B. melitensis
strain 16 M down-regulates caspase-2 transcriptional levels and
inhibits transcription of genes involving mitochondria activities at
an early stage of infection [6]. No caspases were up-regulated in
strain 16M-infected macrophages. These results suggest that
smooth virulent Brucella modulate macrophage cell death by
inhibiting mitochondrial cell death pathway and caspase activation.
The caspase gene expression profiles in macrophages infected with
rough Brucella strains have not been studied.
We hypothesized that rough B. abortus strains would induce
macrophage cell death through a caspase-dependent pathway. To
test this hypothesis, we used rough B. abortus strains RB51 [30] and
RA1 [31] as compared with their parent smooth virulent strain 2308
(S2308). The live attenuated rough strain RB51 serves as the official
Brucella cattle vaccine and has been used in the US since 1996 [32].
The use of RB51 as a vaccine has the advantage that it does not
stimulate Brucella O antigen specific antibodies and thus does not
interfere with the diagnosis of wild type Brucella infection in the field.
The rough phenotype of RB51 is due to the mutation of wboA that
encodes a glycosyltransferase [33]. Compared to its parent strain
S2308, RB51 has at least one additional mutation of rpoB [34]. B.
abortus RA1 is a single wboA Tn5 rough mutant of S2308 [31]. Just as
to RB51, RA1 lacksthe O side chain and isattenuated. Elucidation of
the mechanisms underlying of Brucella rough strains RB51 and RA1
induced macrophage response will improve our understanding of
Brucella vaccine immunity and foster our goal of developing an
effective vaccine against human brucellosis. The results presented
here demonstrate that RB51 and RA1 induce a novel apoptotic and
necrotic macrophage cell death pathway mediated by caspase-2.
Results
RB51 and RA1 induce apoptotic and necrotic
macrophage cell death
The programmed cell death of Brucella-infected macrophages
was first analyzed by Annexin V (green) and propidium iodide (PI,
red) staining. Fluorescein-conjugated Annexin V detects translo-
cation of phosphatidylserine from the inner cell membrane to the
outer cell membrane of cells at the early stage of apoptosis. PI
stains the DNA of necrotic cells and/or cells at late stage of
apoptosis [35]. The results of fluorescence staining of infected
macrophages indicated that rough B. abortus strains RB51 and
RA1 induce both apoptotic (stained green) and necrotic (stained
green and red) macrophage cell death. At 24 h post infection with
RB51 or RA1, 61.5%68.7% or 74.7%65.6% of the infected
macrophages, respectively, underwent either apoptotic or necrotic
cell death (Figure 1A, Table 1). The cytopathic effect of rough
Brucella on macrophages was further confirmed by the lactate
dehydrogenase (LDH) release assay, a nonradioactive cytotoxicity
assay used to monitor the LDH release from dying membrane-
damaged macrophages (Figure 1B).
The kinetic profiles of intracellular survival of different Brucella
strains were analyzed in parallel with the cell death of infected
macrophages (Figure 1C). Macrophage cells were infected with
RB51 or RA1 at a multiplicity of infection (MOI) of 200 that has
been commonly used for Brucella infection studies [12,36]. Neither
RB51 nor RA1 survived inside macrophages as demonstrated by
continuous decline of survived bacterial numbers inside macro-
phages. In contrast to these rough Brucella strains, a less amount of
smooth strain 2308 (S2308) cells was taken up by macrophages at
a MOI of 200 (data not shown). This observation is consistent with
other reports [8,12]. At 1 h post infection, the number of
internalized S2308 cells found inside macrophages at the MOI
of 2,000 was similar to the number of internalized RB51 or RA1
cells at a MOI 200 (Figure 1C). At 24 h post infection, the number
of living S2308 cells was significantly higher than that of S2308 at
6 h post infection and that of RB51 or RA1 at 24 h post infection.
These results indicated that S2308 survived and replicates inside
macrophages. However, S2308 failed to induce any macrophage
cell death, even with a MOI of 2,000, at 24 h post infection
(Figure 1A and 1B).
Programmed cell death of Brucella-infected macrophages was
confirmed and further analyzed by Hoechst 33342 and Annexin V
straining (Figure 2). Apoptotic cells were detectable as early as 2 h
post infection with RB51 (Figure 2). The level of cell death
increased to about 16.3%62.1 at 4 h post infection. Approxi-
mately, 19.5%62.9% macrophage cells exhibited both Annexin-V
and PI positive (necrotic cell) among the dead cells population at
4 h post infection. At 6 h after infection, 26.6%63.5% of cells was
membrane-damaged macrophages as established by a lactate
dehydrogenase (LDH) releasing test (Figure 1B). Of the dying cells,
70.3%65.9% were necrotic or late-apoptotic cells. Others are
early apoptotic cells (Figure 2A). RB51-induced apoptotic
macrophage cell death was confirmed by staining with Hoechst
33342. The RB51- and RA1-infected macrophages exhibited
typical signs of apoptosis, i.e., condensed nuclei and shrunken cells
(Figure 2B).
To specifically study Brucella internalization by individual
macrophages, a recombinant strain RB51GFP that expresses the
green fluorescent protein (GFP) [37] was used to infect
macrophages. Over 95% of macrophages were infected with
RB51GFP at any tested MOI (20, 200, and 2000) at 1 h post
infection (Figure 3A). The bacteria infection rate for individual
macrophages was uneven in any tested MOI. Some macrophages
were infected with more bacteria than others. With a low MOI of
20, the majority of RB51GFP-infected macrophages contained 2–
12 green fluorescence dots per macrophage (Figure 3A). The
higher MOIs usually resulted in increased numbers of infected
bacteria per macrophages. The PI staining of RB51GFP-infected
macrophages allowed us to simultaneously monitor macrophage
Casp2 in Brucella Pathogenesis
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was found that most cell death occurred in Brucella-infected
macrophages. For example, in macrophages infected with
RB51GFP for 6 h (MOI: 200), most dying macrophages contained
intracellular bacteria shown by green fluorescence (Figure 3B). A
small number of PI-positive dying cells were not surrounded by
green fluorescence probably due to the disruption of cell
membrane leading to the release of bacteria. This possibility was
observed by comparing the images of light microscopy and
fluorescence microscopy.
To further determine the relationship between the infection dose
of Brucella and macrophage cell death, a kinetic experiment was
conducted (Table 1). In this experiment, macrophages were infected
with different MOIs and cell death evaluated at different time points
(4,8,24,and 48 h)followinginfection.Itwasfoundthattheleveland
speed of macrophage cell death were dependent on the infection
doses ofroughBrucella. The macrophagecelldeath induced byRB51
with the MOI of 2,000 developed much faster than that with a MOI
of 200 or 20 (Table 1). Heat killed RB51 (HK-RB51) only caused
limited cell death (,10%) at a MOI of 2000 at 24 and 48 h post
infection.S2308didnotinduceobviouscelldeathatanytestedMOI.
To test if the same cell death also occurs in bone marrow
derived macrophages (BMDM) infected with rough Brucella strains,
BMDM were prepared using BALB/c mice and infected with
different Brucella strains. Live RB51 or RA1 was also capable of
inducing apoptotic and necrotic cell death in BMDM. Heat-killed
RB51 or RA1 did not cause obvious cell death with a MOI of 200.
It suggests that viable rough strains are required to induce
macrophage death. Live smooth strain S2308 did not induce cell
death of infected BMDM (Figure 4).
RB51 induces apoptosis and necrosis in primary
peritoneal macrophages isolated from RB51-vaccinated
mice
Vaccine strain RB51 has been widely used for studying
protective mechanisms against brucellosis using mice [30,38]. In
order to determine if RB51 or S2308 induces similar cell death in
primary macrophages in RB51-infected mice, BALB/c mice were
injected intraperitoneally (i.p.) with RB51, HK-RB51 or S2308 at
a dose of 5610
8 CFU. This is the same dosage and injection route
used for other typical RB51 mouse studies [39,40]. Peritoneal
macrophages were collected and monitored for induction of
Figure 1. Cell death of macrophages infected with B. abortus strains RB51,RA1 and their parent wild type S2308. (A) RB51 and RA1
induced 61.5%68.7% and 74.7%65.6% macrophage cells death, respectively, at a MOI of 200 at 24 h post infection. B. abortus strain 2308 induced
limited macrophage cell death even at the MOI of 2,000. (B) LDH release from RB51, RA1 and S2308 infected macrophages. The data represent the
means6standard deviations for three independent experiments. The asterisk (*) represents the significant differences (P,0.05) of the LDH release
level from macrophages infected by smooth S2308 compared to that from macrophages infected with rough strain RB51 or RA1. (C) Growth kinetics
of RB51, RA1 and S2308 in macrophages. The number of internalized cells of S2308 at MOI 2,000 found was similar to the number of cells of
internalized RB51 and RA1 at a MOI 200 at 1 h post infection. The asterisk (*) represents the significant differences (P,0.05) in survival level of smooth
S2308 compared to that of rough strain RB51 or RA1 inside infected macrophages.
doi:10.1371/journal.pone.0006830.g001
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macrophages from RB51-vaccinated mice showed apoptotic or
necrotic staining at 24 h after infection (Figure 5). Macrophages
infected with Brucella S2308 appeared to be activated as
demonstrated by the larger size and irregular shape with long
pseudopodia, as compared with noninfected macrophages that
showed smaller size and oval shape with less short cytoplasmic
processes. Similar observation was found in macrophages treated
with HK-RB51. In addition, no obvious cell death was observed in
macrophages from control mice injected with saline, HK-RB51 or
S2308. These results indicate that RB51 induces apoptosis and
necrosis in primary macrophages from RB51-vaccinated mice.
Inhibition of caspase-2 inhibits RB51 and RA1-induced
macrophage cell death
The role of caspases in rough B. abortus-induced macrophage
cell death was examined. Peptide-based substrates and inhibitors
have been used extensively to monitor the association of caspases
with cell death and to identify the caspases involved [41,42].







2,000 4 2 ++ -
8 2 +++ -
24 2 ++++ +
48 2 ++++ +
200 4 2 + -
8 2 ++ -
24 2 +++ 6
48 2 ++++ 6
20 4 222
8 2 6 2
24 2 + 2
48 2 + 2
aHours Post Infection.
bResults of Annexin V and/or PI staining of macrophages infected with
indicated bacteria: ++++, 75 to 100% positive; +++, 50 to 75% positive; ++,2 5
to 50% positive; +, 5–25% positive; 6, ,5% positive; -, no positive staining.
doi:10.1371/journal.pone.0006830.t001
Figure 2. Apoptotic and necrotic macrophage cell death
induced by RB51. (A) Annexin V/PI staining shows both apoptosis
(solid arrow) and necrosis (hollow arrow) of macrophages at as early as
2 h post infection. (B) Staining with Hoechst 33342 shows cell shrinkage
and nuclear condensation (diamond head arrow) of infected macro-
phages at 6 h post infection at a MOI of 200. The results are a
representative of three independent experiments.
doi:10.1371/journal.pone.0006830.g002
Figure 3. Analysis of the relationship between internalization
of rough Brucella and macrophage cell death. (A) Uneven
macrophage internalization of RB51GFP with different infection MOIs
observed at 1 h post infection. (B) Most cell death occurred in
macrophages infected with RB51GFP (MOI: 200) at 6 h post infection.
The results are a representative of three independent experiments.
doi:10.1371/journal.pone.0006830.g003
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VAD-FMK prior to infection with RB51 or RA1 resulted in an
approximate 69.4%64.9% or 63.2%64.8%, respectively, de-
crease in macrophage cell death at 24 h post infection compared
to untreated infected macrophages (Figure 6). These results suggest
that RB51 and RA1-induced macrophage cell death is mediated
by a caspase(s). To determine the potential role of individual
caspases in the macrophage death, a series of nine caspase
inhibitors were tested for inhibition of cell death. The caspase-2
specific inhibitor (Z-VDVAD-FMK) blocked macrophage cell
death caused by RB51 or RA1 98.2 %60.5% or 80.3%65.2%,
respectively, compared to untreated controls at 24 h post infection
(Figure 6). The caspase-2 inhibitor appears to exert a greater
influence in preventing cell death in RB51-infected macrophages
than in RA1-infected macrophages; it might be attributed to the
differences in the gene mutations of these two strains. The
difference in inhibition of macrophage cell death provided by the
caspase-2 inhibitor over that of the pan-caspase inhibitor may be
attributed to the difference in the specificities of these inhibitors.
The inhibitors of caspase -1, 3, 4, 6, 8, 9, 10, and 13 failed to
significantly inhibit RB51 and RA1-induced macrophage cell
death in our studies. These results support our hypothesis that the
rough Brucella abortus strains induce macrophage cell death is
mainly mediated by caspase-2.
Caspase-2 is activated at an early stage of infection
Caspase-2 activation was analyzed by caspase colorimetric assay
and procaspase cleavage assay. The caspase colorimetric assay
showed that caspase-2 enzyme activity of RB51 and RA1 infected
macrophages increased approximately 59.9%68.3% (p,0.05) and
55.7%61.9% (p,0.05) respectively at 1 h post infection. This
increase was transient. It was followed by a rapid return to the
base line at 2 h post infection (Figure 7A). Capsase-2 activation
was analyzed further by detection of the cleavage of procaspase-2
protein [29]. As ascertained by western blot analysis, transient
decrease in the level of procaspase-2 (48 kDa) in RB51 or RA1-
infected macrophages was observed at 1 h, 2 h and 6 h post
Figure 4. Apoptotic and necrotic cell death of bone marrow derived macrophages infected with viable rough B. abortus strains RB51
or RA1 (MOI: 200) at 24 h post infection. Smooth strain S2308 (MOI: 2000) and heat-killed RB51 and RA1 (equivalent MOI: 200) did not induce
obvious macrophage cell death. The results are a representative of three independent experiments.
doi:10.1371/journal.pone.0006830.g004
Figure 5. Apoptotic and necrotic cell death in peritoneal
primary macrophages isolated from RB51-vaccinated mice.
Annexin V/PI staining shows both apoptosis and necrosis of peritoneal
macrophages at 24 h after infection with RB51. No obvious cell death
was observed in peritoneal macrophages from mice injected (i.p.) with
S2308 or heat-killed RB51 (HK-RB51). The results are a representative of
three independent experiments.
doi:10.1371/journal.pone.0006830.g005
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caspase-2 occurs at the early stage of infection. In contrast, S2308
did not induce significant changes in the caspase-2 enzyme activity
or the level of procaspase-2 (Figure 7A and B). Caspase-1 activity
was also examined in RB51 or RA1-infected macrophages. No
significant changes were observed (data not shown).
The above results indicate that rough strains RB51 and RA1
induce similar apoptotic and necrotic cell death in macrophages
and that the cell death is mediated by caspase-2. We later focused
on comparing RB51 and its parent smooth strain 2308 to further
study the apoptotic and necrotic cell death mechanism induced by
rough B. abortus.
Inhibition of caspase-2 activity increases RB51 survival in
macrophages
To confirm the inhibition of programmed macrophage cell
death after treatment with the caspase-2 inhibitor, the LDH
release assay was used to monitor cytopathic cells (Figure 8A). The
LDH released from RB51-infected macrophages reached a value
of 54.6%66.5% of the total LDH available in both living and
dying cells at 8 h post infection, and 80.5%66.4% at 24 h post
infection. In contrast, after pretreatment with the caspase-2
inhibitor, the yield of LDH released was 9.3%66.0% and
24.7%613.3% at 8 h and 24 h post infection, respectively.
Inhibition of caspase-2 activity also increased the number of
RB51 survived inside macrophages (Figure 8B). The inhibitor did
not change the phagocytosis of RB51 by macrophage cells as
demonstrated by similar number of living brucellae with or
without the caspase-2 inhibition at 1 h post infection. At 8 h post
infection, approximately 5% of RB51 survived inside infected
macrophage cells. However, after the pretreatment of the
macrophages with the caspase-2 inhibitor prior to RB51 infection,
approximately 36% of brucellae survived in the macrophages. At
24 h post infection, the number of RB51 surviving inside the
macrophages pretreated with the caspase-2 inhibitor was approx-
imately 120 times greater than that inside untreated macrophages
(Figure 8B). This phenomenon might be related to more cells
survived due to the inhibition of macrophage cell death.
Knockdown of caspase-2 expression decreases RB51-
induced macrophage cell death
Using different specific caspase inhibitors, the present studies
demonstrate that caspase-2 plays an important role in rough B.
abortus induced macrophage cell death. To address potential
concerns as to the specificity of the caspase inhibitors [43], the
RNA interference (RNAi) technique [44] was used to further
identify the role of capase-2. RNAi is a natural, evolutionarily
conserved regulatory mechanism that is mediated by the
introduction of dsRNA into the cytoplasm of a host cell. RNAi
has provided a unique tool for sequence-specific silencing to
develop practical strategies for studying gene function, biological
processes and pathway analysis [44]. Short hairpin RNA (shRNA)
is a sequence of RNA that makes a tight hairpin turn that silences
gene expression via RNAi [45]. Macrophages with specific gene
knockdown were generated by transfection of macrophages with
lentivirus vectors expressing gene-specific shRNA [46]. Four
caspase-2 knockdown clones (RAW264.7-Casp2KD) and two
control clones (RAW264.7-GipZ) were selected based on EGFP
fluorescence detection. The protein expression of caspase-2 was
further monitored by Western blot analysis (Figure 8A).
RAW264.7-GipZ cells did not exhibit any difference in procas-
pase-2 expression compared with the original RAW264.7 cells.
The expression levels of procaspase-2 protein in four RAW264.7-
Casp2KD clones decreased by 34–64%. When infected with
RB51 at a MOI of 200 for 6 h, the control RAW264.7-GipZ
clones demonstrated a similar rate of cell death compared to the
Figure 6. Inhibition of rough B. abortus-induced macrophage cell death by a pan-caspase inhibitor and a caspase-2 inhibitor.
Macrophages were pretreated with individual caspase inhibitor and then infected with RB51 or RA1 at a MOI of 200. No inhibition was observed with
any of the other caspase inhibitor. The results are a representative of three independent experiments.
doi:10.1371/journal.pone.0006830.g006
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RAW264.7-Casp2KD clones showed a significantly lower rate of
cell death rate (5–44%) (P,0.05) (Figure 9B). Of the four
RAW264.7-Casp2KD clones, clone two had the lowest cell death
rate (5%60.6%) and is correlated with the lowest caspase-2
protein expression (Figure 9). These results confirm that RB51-
induced apoptosis is mediated specifically by caspase-2.
Mitochondrial membrane potential (MMP) decreases
following cytochrome c release
Mitochondria are viewed as the major players in both necrotic
and apoptotic cell death [47,48]. A key feature of apoptotic and
necrotic cascades is the initiation of the mitochondrial permeabil-
ity transition (MPT) followed by the release of cytochrome c from
mitochondria. We hypothesized that RB51 induced apoptotic
macrophage cell death by activating a mitochondria-dependent
apoptotic pathway. Increased MPT results from a decrease of
MMP. Decreased MMP promotes a decrease in the retention of
the lipophilic cationic dye 3,39-dihexyloxycarbocyanine iodide
(DiOC6). This phenomenon is frequently used to quantify MMP
through flow cytometry [49] and was applied in this study. A
MMP decrease of 23.5%65.8% (P,0.05) was detected in RB51-
infected macrophages at 1 h post infection. At 6 h post infection,
the level of MMP decreased to 28.5%60.7% (P,0.05) of the
value of uninfected macrophages. The MMP of RB51-infected
macrophages remained at a low level for 24 h post infection
(Figure 10A). The MMP of S2308-infected macrophages increased
33.0%610.5% (P,0.05) at 1 h post infection but after 2 h post
infection returned to the level found with the uninfected
macrophages (Figure 10A).
A direct effect of the increased MPT and decreased MMP is the
release of cytochrome c from the mitochondria to the cytoplasm.
To test this effect, the cytochrome c levels from the cytosol of
infected and uninfected macrophages from the same experiment
were analyzed (Figure 10B). Release of cytochrome c into the
cytoplasm of RB51-infected macrophage was detectable as early as
2 h post infection (Figure 10B). No cytochrome c was detected in
Figure 7. Caspase-2 enzyme activity in infected macrophages
induced by RB51 but not by S2308. (A) Analysis of caspase-2
activities by a colorimetric assay. The asterisk (*) represents significant
differences (P,0.05) compared to the medium control group. (B)
Western blot analysis of precaspase-2 in infected macrophages. The
numbers shown in the figure represent the amounts of procaspase-2
quantified by densitometry and normalized to the b-actin content. The
data represent the means6standard deviations from three indepen-
dent experiments.
doi:10.1371/journal.pone.0006830.g007
Figure 8. Decreased cell death of infected macrophages and
increased RB51 survival inside macrophages with the usage of
the caspase-2 inhibitor. Macrophages pretreated with Z-VDVAD-
FMK were infected with RB51 for 24 h at a MOI of 200. (A) Macrophages
pretreated with the caspase-2 inhibitor and infected with RB51 released
less LDH than infected cells lacking inhibitor. (B) Growth kinetics of
RB51 in macrophages. The number of RB51 cells surviving inside
macrophages pretreated with the caspase-2 inhibitor was approxi-
mately 120 times greater than the number of cells found in untreated
macrophages (P,0.05). The asterisk (*) represents significant difference
(P,0.05) in the LDH release or bacterial CFUs from RB51-infected
macrophages with caspase-2 inhibitor treatment compared to that
without caspase-2 inhibitor. Data represent the means6standard
deviations from three independent experiments.
doi:10.1371/journal.pone.0006830.g008
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infection.
Discussion
The results reported here indicated that attenuated rough B.
abortus strains RB51 or RA1, but not their parent smooth virulent
strain 2308, induced both apoptosis and necrosis in RAW264.7
macrophage cells, bone marrow-derived macrophages, and
peritoneal macrophages. The programmed cell death induced by
rough B. abortus is mediated primarily by caspase-2 and through a
mitochondria-dependent cell death pathway. Since rough strains
RB51 and RA1 have deficient LPS O antigen found in their
parent strain S2308, the rough Brucella phenotype with deficient O
antigen plays a critical role in caspase-2-mediated macrophage cell
death induced by rough Brucella.
Cell death of macrophages infected with rough Brucella strains
has been discovered by several groups [9,10,11,12,13]. The
discovery of cell death induced by rough Brucella was first reported
by Freeman et al in 1961 [11]. Fernandez-Prada et al later found
that a rough B. melitensis mutant WRR51 lacking a wboA gene
carried by smooth virulent B. melitensis strain 16 M resulted in
apoptotic cell death in human monocytes from healthy volunteers
[9]. Our results are consistent with this finding. Pei et al also
showed that several rough B. abortus strains obtained from a
transposon mutation induced necrotic and oncotic macrophage
cell death [12]. No apoptotic macrophage cell death was observed
in this report. One possible reason for the difference in the
observed cell death patterns might be that different rough mutants
were used in each study [12,50]. The rough phenotype can result
from mutations affecting O antigen precursor synthesis, its
polymerization and transport, or from defects in the inner core
oligosaccharide [50]. The structure of rough lipopolysaccharide
present in each mutant may vary. Different levels of necrotic/
oncotic macrophage cell death may also be induced by rough B.
abortus mutants with distinct gene mutations. For example, at the
MOI of 200, macrophage cell death was induced by rough strain
CA180 (mutation of manA encoding phosphomannomutase) but
not by rough strain CA533 (mutation of a rfbD-like gene encoding
a putative GDP-D-mannose dehydratase) at 8 h post infection
[12]. The observation that RB51 and RA1 induce similar patterns
of macrophage cell death suggests that the wboA gene mutation in
RB51 is a primary player in the apoptotic and necrotic cell death.
The absence of Brucella O antigen may not directly contribute to
the induction of macrophage cell death by rough Brucella. While
RB51 does not induce detectable antibodies in animals against
Brucella O antigen, RB51 has been found to produce a low but
detectable level of O antigen [51]. Gonzalez et al. [50] generated
rough Brucella mutants by transposon mutagenesis of more than 10
genes involved inO antigen(orO chain) or the core oligosaccharide
biosyntheticpathways. Theseroughmutants areclassifiedinto three
types based on the decrease in LPS molecular weight. Therefore,
rough Brucella strains are defined by deficient O antigen instead of
completely deleted O antigen. The reason of macrophage cell death
Figure 9. Inhibition of RB51-induced macrophage cell death by
caspase-2 shRNA. Macrophages with or without caspase-2 shRNA
were infected for 6 h with RB51 at a MOI of 200. (A) Caspase-2
expression in different clones was detected by Western blot analysis.
The numbers shown in the figure represent the amounts of procaspase-
2 that were quantified by densitometry and normalized to the b-actin
data. (B) The LDH assay was used to detect differential cell death in
different macrophage clones. The asterisk (*) represents significant
differences (P,0.05) of LDH releases from different clones compared to
that from the parent RAW264.7 cells. The data represent the
means6standard deviations from three independent experiments.
doi:10.1371/journal.pone.0006830.g009
Figure 10. Decreased mitochondrial membrane potential
(MMP) and increased cytochrome c release from mitochondria
in RB51-infected macrophages (MOI: 200). Infection with S2308 at
a MOI of 2,000 did not cause decrease of MMP or cytochrome c release.
(A) The results of flow cytometry results were summarized in graphic
form, and represent the means6standard deviations of three indepen-
dent experiments. The asterisk (*) represents significant differences
(P,0.05) compared to the medium control group. (B) Cytochrome c
release was analyzed by Western blot analysis. b-actin was used as a
reference. Only cytoplasmic portion of cell lysates was assayed. The
results are a representative of three independent experiments.
doi:10.1371/journal.pone.0006830.g010
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O antigen.Instead,thecelldeathismost likelyduetothepleiotropic
effect of removing the majority of the O antigen that results in the
change of the Brucella cell envelope structure. The LPS defects alter
key topological, physiochemical and biological surface properties of
rough Brucella [50]. The outer membrane proteins and lipids in
rough Brucella cells are readily exposed to the host environment,
making them much easier to interact with the host cells. It has also
beenfoundthat thesurfaceofroughBrucellaout membraneis highly
hydrophobic and negatively charged [50]. Such a surface may allow
multiple nonspecific interactions with eukaryotic membranes.
Therefore, Brucella O antigen probably acts as a negative modulator
of non specific adherence which allows receptors to function [50]. It
has been observed that rough mutants penetrate more actively and
display higher adherence to macrophages than smooth strains
[52,53,54]. Rough and smooth Brucella strains enter macrophages
through different mechanisms. Virulent smooth Brucella cells use
lipid rafts to enter murine macrophages while rough Brucella cells do
not [55]. We found similar numbers of internalized brucellae inside
macrophages when rough strain MOI was 200 and smooth strain
MOI was 2000 (Figure 1). The MOI of 200 of rough strain induced
significant cell death, while smooth strain 2308 did not induce
obvious cell death even with an MOI of 2000. The results also
suggest that different outcomes of macrophage cell death is
primarily due to the difference of rough vs. smooth phenotypes
instead of the different numbers of phagocytosed Brucella cells.
Pei et al [9,10,11,12,13] found that viable intracellular rough
Brucella were required for inducing cytopathic effect on infected
macrophages. Although heat-killed rough brucellae were internal-
ized as efficiently as live bacteria, they did not induce macrophage
cell death [9,10,11,12,13]. Our study is consistent with the
conclusion although a very high MOI of 2,000 induced limited but
detectable macrophage cell death at late infection stage (Table 1).
Pei et al. [12] further found that protein synthesis from live rough
Brucella cells is required for induction of macrophage cell death. It
was shown that inhibition of bacterial synthesis and replication by
chloramphenicol treat prevented cell death of infected macro-
phage [13]. It is interesting that viable but not killed smooth
Brucella inhibit spontaneously occurring apoptotis in human
macrophages [5,6,7]. How live rough Brucella promotes apoptotis
and live smooth Brucella inhibits apoptosis is an important question
for better understanding Brucella pathogenesis and host responses
against Brucella infections.
The relationship between rough Brucella-induced apoptotic and
necrotic macrophage cell death may be complex. Necrosis refers to
the sum of changes secondary to cell death by another mechanism
such as apoptosis [17,21,22]. Our study showed that macrophage
cell death induced by rough Brucella was dose-dependent since
more cell death was observed with higher MOIs (Table 1,
Figure 3). Meanwhile, the numbers of internalized bacteria in
infected macrophages might not be even. Some macrophages
phagocytosed more rough bacteria than others with the same
MOI (Figure 3). Macrophages infected with more rough Brucella
cells tended to induce more and quicker macrophage cell death.
Necrosis occurred more than apoptotis in the late stage of Brucella-
induced macrophage cell death. Therefore, it is likely that
apoptotic and necrotic cell death of Brucella-infected macrophages
represents different stages of the same cell death pathway, from
early and late apoptosis to eventual necrosis. Alternatively, a non-
apoptotic pathway(s) of cell death might be induced in some
infected macrophages, which results in necrosis. Further investi-
gation is needed to test this possibility.
Caspase-2 is activated in response to embryonic development
[56] and many biological stresses, including DNA damage, aging,
UV irradiation, tropic factor withdrawal, endoplasmic reticulum
stress, death receptor activation and heat shock [57,58,59].
Deficient caspase-2 activation has been observed in gastric cancer,
and acute myeloblastic leukemias [60,61]. Caspase-2 activation
has also been observed in host cells infected with Salmonella [29]
and Epstein-Barr virus [62]. Salmonella typhimurium induced
primarily caspase-1-mediated pro-inflammatory pyroptosis
[23,24,25]. The action of caspase-2 was also needed for
Salmonella-induced apoptosis as shown by the results of experiments
using caspase-2 knockout macrophages and chemical caspase-2
inhibitors [29]. Unlike with S. typhimurium, rough (but not smooth)
B. abortus-induced macrophage cell death exhibits caspase-2
activation and is noticeable hampered by a caspase-2 inhibitor
and caspase-2-specific shRNA (Figure 6 and 9). On the other
hand, the macrophage cell death induced by rough B. abortus
strains RB51 and RA1 were not obviously inhibited by a caspase-1
inhibitor (Figure 6). These findings suggest that caspase-1 plays
minimal role in the Brucella-induced cell death. Loss of mitochon-
drial integrity and release of cytochrome c do not occur during
pyroptosis [17] but was observed in macrophages infected with
RB51 and RA1. This difference indicates that pyroptosis does not
play a major role in rough Brucella-induced cell death. Unlike
virulent Salmonella and Shigella strains which induce apoptosis in
infected macrophages, smooth virulent Brucella strains inhibit
programmed macrophage cell death and replicate in macrophages
[5,6,7,9,63]. The current study further indicates that B. abortus
smooth strain S2308 does not induce caspase-2 activation or
macrophage death. Therefore, the caspase-2-mediated macro-
phage apoptosis induced by rough attenuated strains but inhibited
by the parent wild type appears to be a novel findings not as yet
found in other bacterial pathogen.
How caspase-2 mediates programmed cell death of macrophages
infected by rough Brucella is unclear and deserves further
investigations. Across species caspase-2 is one of the most conserved
caspases. Its function in cell death signaling is still an enigma [64].
Caspase-2 is unique among the caspases in that it has features of
both upstream and downstreamcaspases.Caspase-2contains a long
CARD prodomain that can be used to interact with adaptor
proteins. This is typical of initiator caspases. On the other hand, the
predicted cleavage specificity of caspase-2 appears to place it to be
an effector caspase similar to caspases-3 and -7 [58]. The present
studies reveals that caspase-3 or caspase-8 inhibitor slightly yet not
significantly inhibits RB51- and RA1-induced macrophage cell
death. The caspase-3 inhibitor (Z-DEVD-FMK) was reported to
also inhibit caspase-7 activity [65]. It is possible that caspase-2
functions as an initiator caspase and regulates apoptotic activities of
other effector caspases (e.g., caspase-3, -7 and -8). It is also possible
that caspase-2 regulatesBrucella-induced cell death directly byacting
as an effector caspase. This hypothesis is supported by the
observation that caspase-3 and caspase-8 have the potential to
regulate downstream caspase-2 activity [7,64,66]. An alternative
possibility is that caspase-2 may function as an initiator caspase and
effector caspase at the same time.
The study provides new evidence to support the hypothesis that
smooth virulent Brucella has the ability to control or influence
mitochondrial functions, especially those related to programmed
cell death in macrophage cells, via a mechanism that is a crucial
survival mechanism in this pathogen. Virulent Brucella strain
S2308 appears to inhibit macrophage cell death by inhibiting
mitochondrial membrane transition and cytochrome c release
(Figure 10). The inhibition of macrophage cell death allows Brucella
survive and replicate inside macrophages. In contrast, rough
Brucella strains induce macrophage cell death through the release
of cytochrome c from the mitochondria. The dying macrophages
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es. It is interesting to note that the Brucella species are classified as
a-Proteobacteria, the modern-day relatives of an ancient endo-
symbiont that gave rise to mitochondria [67,68]. Our previous
study indicates virulent B. melitensis strain 16 M inhibited
mitochondria activities at an early stage of infection [6]. The
interactions between mitochondrial permeability transition and
caspase-2 activation in the apoptotic cell death are still unclear. It
has been repeatedly proposed that caspase-2 can act upstream of
mitochondrial events as an initiator that triggers cytochrome c
release and subsequent apoptosome formation, either directly or
through generation of tBid [58,64,69]. Other studies place
caspase-2 neither upstream nor downstream but suggest it acts
in concert with the mitochondrial as well as the death receptor
pathways of apoptosis [70]. Our results suggest that programmed
cell death in macrophages infected with rough B. abortus is at least
partially due to the mitochondrial permeability transition and
cytochrome c release. The relationship between mitochondrial
permeability transition and caspase-2 activation in the apoptotic
cell death of Brucella-infected macrophages requires further
investigation.
The caspase-2-mediated cell death of macrophages infected
with vaccine strain RB51 and vaccine candidate RA1 may help us
to better understand the process of protective Brucella immunity.
Programmed cell death of macrophages infected with many
pathogens (e.g., M. tuberculosis, Salmonella, Influenza virus) plays an
important role in antigen presentation to T cells through a process
called cross-priming [71]. It is likely that rough Brucella-induced
macrophage cell death may play an important role in protective
immunity against brucellosis through cross-priming or other
mechanisms. Further understanding of Brucella-induced pro-
grammed cell death will undoubtedly help decipher Brucella
pathogenesis and promote rationale Brucella vaccine development.
Materials and Methods
Bacterial strains and macrophage cell culture
B. abortus vaccine strain RB51, strain RA1 and the parent wild
type strain S2308 were originally obtained from Dr. Gerhardt G.
Schurig’s laboratory at Virginia Tech. B. abortus strain RB51GFP
that contains a GFP plasmid (pNSGroE/GFP) was a gift from Dr.
Nammalwar Sriranganathan’s laboratory at Virginia Tech [37].
These bacterial strains were grown either in tryptic soy broth or on
tryptic soy agar plates. Heat-killed Brucella was prepared by boiling
bacteria for 20 min. The characteristics of these strains were
confirmed with AMOS (abortus-melitensis-ovis-suis) PCR reactions
[72], crystal violet staining, antibiotic resistance, urease test, and
thionin and fuchsin susceptibility [73]. To minimize naturally
mutated rough phenotypes in smooth strain S2308, one single
colony of smooth phenotype S2308 was selected based on crystal
violet staining and used for bacterial amplification. All studies
utilizing Brucella strains were performed in a Biosafety level 3 (BSL-
3) laboratory. Murine macrophage cell line RAW264.7 (ATCC
#TIB-71) was cultured at 37uC with 5% CO2 in complete tissue
culture medium (c-DMEM) consisting of Dulbecco’s modified
Eagle’s medium (DMEM; ATCC) supplemented with 10% heat-
inactivated fetal bovine serum (HyClone, Logan, Utah). Macro-
phages between passages 4 through 15 were used in these
experiments. Bone marrow-derived macrophages (BMDM) were
prepared from BALB/C mice and were cultured at 37uC with 5%
CO2 in RPMI-1640 supplemented with 10% heat-inactivated fetal
serum and 30% L-Cell Medium as previously described [74].
Bacterial and macrophage cells were maintained under conditions
that sustained exponential growth.
Macrophage infection assays
Macrophage cells were cultured in 96-well, 24-well, or six-well
plates. In the macrophage infection experiments, 5610
4 cells per
well were seeded in 96-well plate and 2.5610
5 cells per well were
seeded in 24-well plate. For flow cytometry assays, 1610
6 cells were
seeded per well in six-well plate. The macrophages were cultured
overnight prior to infection with RB51, RA1 or S2308 cells.
MacrophageswereinfectedwithBrucellaatamultiplicityofinfection
(MOI)of20,200 or2,000.Theplateswere centrifugedat300xg for
5 min. All incubations with Brucella were conducted at 37uCi na n
atmosphere containing 5% (vol/vol) CO2. After 30 min the cells
were washed three times with Dubecco’s phosphate buffered saline
(DPBS), and incubated in fresh DMEM supplemented with 50 mg/
ml of gentamicin to kill extracellular bacteria. A specific caspase
inhibitor might be included in the cell culturing. For caspase
inhibition studies, a caspase inhibitor sample pack (R&D systems
Inc, Minneapolis, US) was used which contains a pancaspase
inhibitor (Z-VAD-FMK) and nine specific caspase inhibitors
including those for inhibition of caspase-1 (Z-WEHD-FMK),
caspase-2 (Z-VDVAD-FMK), caspase-3 (Z-DEVD-FMK), cas-
pase-4 (Z-YVAD-FMK), caspase-6 (Z-VEID-FMK), caspase-8 (Z-
IETD-FMK), caspase-9 (Z-LEHD-FMK), caspase-10 (Z-AEVD-
FMK), and caspase-13 (Z-LEED-FMK). The macrophages were
pretreated with the individual caspase inhibitors at a final
concentration of 20 mM for 1 h prior to infection.
Determination of programmed macrophage cell death
Macrophages were infected in the presence, or absence, of a caspase
inhibitor as described above. Apoptotic or necrotic macrophages were
detected using two approaches. In the first approach, cells were stained
with Annexin V (green dye) and propidium iodide (PI, red dye) using
an Annexin V-FLUOS staining kit (Roche Diagnostics Corporation,
Indianapolis, Ind.). RB51, RA1 or S2308-infected macrophages were
incubated with Annexin V and PI at room temperature for 20 min and
observed by fluorescence microscopy (Nikon TE2000-S microscope).
Images were photographed with an RT Slide Spot digital camera.
Apoptotic and necrotic cell numbers were counted in representative
fields containing at least 200 cells. In the second approach, the nuclei of
RB51 infected cells and untreated control cells were stained with the
blue-fluorescent Hoechest 33342 (Invitrogen, OR)at 1 mg/ml in DPBS
at room temperature for 15 min and observed by fluorescence
microscopy. Gliotoxin-treated cells were employed as a positive control
for apoptotic cell death, and t-butyl-hydroperoxide (TBH)-treated cells
served as a positive control for necrotic cell death [12,13].
Quantitation of cell viability
Cells were cultured in triplicate in 96-well plates infected with
RB51, RA1 or S2308 as described above. The culture supernatants
were collected at various time points, and the lactate dehydrogenase
(LDH) released determined by a CytoTox 96 nonradioactive
cytotoxicity assay (Promega, Madison, Wis.) according to the
manufacturer’s instructions. To reduce the LDH background from
fetal bovine serum, the supernatants were diluted 1:1 with phosphate
buffered saline (PBS) before the assay. The percent of membrane-
damaged dying cells is expressed as a percentage of maximum LDH
release, i.e., 1006(optical density at 490 nm [OD490]o fi n f e c t e dc e l l s
-O D 490 of uninfected cells)/(OD490 o fl y s e du n i n f e c t e dc e l l s-O D 490
of uninfected cells). The data presented represent the average6
standard deviation of at least three separate experiments.
Assay of Brucella survival inside macrophages
Macrophages were seeded in a 24-well plate with 2.5610
5 cells
per well and incubated overnight as described above. RB51, RA1
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above). To assess intracellular survival of Brucella inside macro-
phages, the cells were lysed with 1 ml 0.1% (vol/vol) Triton X-100
in sterile water at selected time points (1, 6 and 24 h). The colony
forming units (CFUs) were obtained by plating a series of dilutions
on TSA plates [75]. All experiments were conducted in triplicate.
Western blot analysis
Cells cultured in six-well plates were infected with RB51, RA1
or S2308 as described above. Cell lysis of the cytosolic fraction was
prepared with a Mitochondria/Cytosol Fractionation Kit (Biovi-
sion) according to the manufacturer’s instructions. Lysates (50 mg
per sample) were analyzed by Laemmli SDS-PAGE and
transferred onto Immobilon P membranes (Millipore) at 150 V
for 1 h in the presence of transfer buffer (25 mM Tris, 192 mM
glycine, 15% methanol, pH 8.3). After transfer, the membranes
were blocked for 1 h a blocking solution (5% low fat dried milk
dissolved in TBS-T (25 mM Tris-HCl, 150 mM NaCl, 0.5%
Tween 20, pH 7.4) and were probed overnight at 4uC with the
mouse anti-caspase-2 (Cell signaling, CA), Rabbit anti-b-actin
(Biovision, CA) or mouse anti-cytochrome c (NeoMarkers, CA)
antibodies. Membranes were washed with PBS-T and incubated
with HRP conjugated to either goat anti-rabbit IgG or goat anti-
mouse IgG (Biovision, CA) at room temperature for 1 h. After
extensive washing with TBS-T, the antigen was visualized using an
ECL Western Blotting Substrate (Pierce). The results were
quantified by densitometry and normalized to the b-actin data.
This experiment was conducted in triplicate.
Caspase-1 and -2 activity assays
Macrophages were cultured in T-25 flasks infected with RB51 or
S2308. The caspase-1 and -2 activities were determined by
monitoring proteolysis of the appropriate colorimetric substrates
using the Caspase ColorimetricAssays(R&DSystems,CA).WEHD
and VDVAD served as substrates employed to detect caspase-1 and
-2 enzyme activities, respectively. All experiments were conducted
in triplicate. The whole-cell lysate was added to a buffer containing
200 mM of the appropriate caspase-specific substrate conjugated to
p-nitroanilide. After an incubation of 37uC for 3 h, caspase activity
was quantified spectrophotometrically at a wavelength of 405 nm
using a VERSAmax microplate reader (Molecular Devices).
Preparation of stable caspase-2 knockdown macrophage
cell lines
Lentivirus vectors Lenti-Casp2miRNA-VSVG (Open Biosystems
OligoIDV2LMM_16681)usedforproducinganti-caspase-2shRNA
and empty lentivirus vector Lenti-GipZ-VSVG were generated at
the University of Michigan shRNA Core Facility. For transduction,
RAW264.7 cells were planted into six-well tissue culture plates at
2.5610
5 per well. On the following day, the cell medium was
aspirated off and replaced with 1.25 ml viral supernatant (MOI of
10) containing 8 mg/ml polybrene into each well. The plates were
gentlyrockedandcentrifugedat2,500 rpmfor90 minat30uCus i ng
an Eppendorf 5810R centrifuge. The medium was replaced after
24 h, and the cells were monitored for enhanced green fluorescent
protein (EGFP) expression. To select the stably transfected cells, at
48 h after transfection, cells were scraped down and planted to
10 cmcellculturedish,selectedwithc-DMEMcontaining10 mg/ml
puromycin.Stablytransfectedcellswereselectedwiththepresenceof
puromycin for over 4 weeks. Puromycin-resistant clones were picked
and expanded. The caspase-2 expression of each clone was
examined by Western blot analysis.
Analysis of mitochondrial membrane potential (MMP)
The loss of mitochondrial membrane potential (DYm) results in
a decrease in the retention of 3,39-dihexyloxycarbocyanine iodide
(DiOC6). The DYm was evaluated by measuring the retention of
the lipophilic cationic dye DiOC6 in mitochondria [49]. Briefly,
cells cultured in six-well plates were infected with RB51 or S2308
in triplicate as described above. At various time points post
infection, the cells were preloaded with 1.5 nM DiOC6 in c-
DMEM incubated at 37uC for 20 min, washed and fixed with 1%
paraformaldehyde at 25uC for 20 min. The cells were then
dislodged with a rubber policeman, pelleted at 500 x g, washed,
and resuspended in PBS containing 1% paraformaldehyde. Flow
cytometry to detect cells with diminished fluorescence was
performed under FL-1 logarithmic amplification using a FACS-
Canto Flow Cytometer (BD Bioscience). Macrophages stained
with an irrelevant isotype antibody source served as controls.
Analysis of cell death of peritoneal primary macrophage
vaccinated with RB51
Female BALB/c mice (three per treatment group) were injected
intraperitoneally with 0.2 ml of a 0.15 M NaCl saline solution
(controls) or 0.2 ml of saline containing approximately
5610
8 CFUs of strain RB51, heat-killed RB51 (HK-RB51), or
S2308. This dose was routinely used for RB51 vaccine efficacy
studies [39,40]. At 2 h post infection, peritoneal macrophages were
isolated from both RB51-immunized and saline-injected mice by
washing the cavity with cold PBS. Cell suspensions were washed
twice with cold complete tissue culture medium (RPMI 1640 with
10% fetal calf serum and 50 mg/ml gentamicin). Isolated peritoneal
cells were counted with 0.4% trypan blue and plated in complete
tissue culture medium at a concentration of 1610
6 cells per well in a
six-well plate. After incubation for 60 min at 37uC in a 5% CO2
atmosphere, the nonadherent cells were removed by washing them
five-time in 2 ml PBS hold at 37uC. The peritoneal macrophages
were incubated in fresh RPMI 1640 supplemented with 50 mg/ml
of gentamicin. Annexin V-FLUOS staining kit (Roche Diagnostics
Corporation, Indianapolis, Ind.) was used to detect the dead
peritoneal macrophage cells 24 h post infection.
Statistical data analysis
Statistical significance was determined using Student’s t-test for
data with two groups and one-way analysis of variance for multiple
group comparison; a P value of ,0.05 was considered significant.
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